| # | Drug | Count |
|---|---|---|
| 0 | ABALOPARATIDE | 1 |
| 1 | ADALIMUMAB | 1 |
| 2 | DROSPIRENONE AND ETHINYL ESTRADIOL | 1 |
| 3 | DUPILUMAB | 1 |
| 4 | ELAFIBRANOR | 1 |
| 5 | SARILUMAB | 1 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | ELAFIBRANOR | 1 | 0.0011 |
| 1 | SARILUMAB | 1 | 0.0000 |
| 2 | ABALOPARATIDE | 1 | 0.0000 |
| 3 | DROSPIRENONE AND ETHINYL ESTRADIOL | 1 | 0.0000 |
| 4 | DUPILUMAB | 1 | 0.0000 |
| 5 | ADALIMUMAB | 1 | 0.0000 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Peroxisome Proliferator-activated Receptor Agonist [EPC] | 1 | 0.0011 |
| 1 | Parathyroid Hormone-Related Peptide Analog [EPC] | 1 | 0.0000 |
| 2 | Interleukin-6 Receptor Antagonist [EPC] | 1 | 0.0000 |
| 3 | Interleukin-4 Receptor alpha Antagonist [EPC] | 1 | 0.0000 |